Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Tech 5: Bitcoin Drops Below US$100,000, Micron Guidance Shakes Investors December 22, 2024 Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence December 22, 2024 Top 5 Canadian Mining Stocks This Week: Omineca Jumps 67 Percent December 21, 2024
Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence December 22, 2024